Showing results (311-320 of 339) with videos related to

Sort By:
Pageof 34
AIDS (London, England)|April 5, 2019
Differences in the rate of nicotine metabolism among smokers with and without HIVRebecca L Ashare, Morgan Thompson, Frank Leone, et al.
Clinical Pharmacology and Therapeutics|December 10, 2020
Transferability of Ancestry-Specific and Cross-Ancestry CYP2A6 Activity Genetic Risk Scores in African and European PopulationsAhmed El-Boraie, Meghan J Chenoweth, Jennie G Pouget, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 28, 2015
Nicotine metabolite ratio (3-hydroxycotinine/cotinine) in plasma and urine by different analytical methods and laboratories: implications for clinical implementationJulie-Anne Tanner, Maria Novalen, Peter Jatlow, et al.
The American Journal on Addictions|March 27, 2021
Comparing the Rate of Nicotine Metabolism Among Smokers With Current or Past Major Depressive DisorderRobert Schnoll, E Paul Wileyto, Anna-Marika Bauer, et al.
Molecular Psychiatry|August 31, 2024
Fine-mapping the CYP2A6 regional association with nicotine metabolism among African American smokersJennie G Pouget, Haidy Giratallah, Alec W R Langlois, et al.
American Journal of Medical Genetics. Part A|April 4, 2003
Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testingJeffrey R Botkin, Ken R Smith, Robert T Croyle, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|August 30, 2008
Translating basic science to improve pharmacotherapy for nicotine dependenceJennifer M Phillips, Steven J Siegel, Alexandra E Shields, et al.
Journal of the National Cancer Institute|July 28, 2022
Leadership Diversity and Development in the Nation's Cancer CentersCaryn Lerman, Chanita Hughes-Halbert, Mary Falcone, et al.
Pharmacogenetics and Genomics|December 13, 2017
Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolismJulie-Anne Tanner, Andy Z Zhu, Katrina G Claw, et al.
Medrxiv : the Preprint Server for Health Sciences|June 6, 2025
MammaTrace - a cell-free DNA methylation plasma only assay for minimal residual disease detection in breast cancer patientsDavid N Buckley, Alex J Kalfa, Gerald Gooden, et al.
Pageof 34